PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
76.46%
Net income growth under 50% of CSIQ's 327.39%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-35.85%
Negative yoy D&A while CSIQ is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-11.27%
Negative yoy deferred tax while CSIQ stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-3.82%
Both cut yoy SBC, with CSIQ at -24.24%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
17.99%
Working capital change of 17.99% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
16.15%
AR growth of 16.15% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
32.92%
Inventory growth of 32.92% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-78.12%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
36.80%
Growth of 36.80% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-99.53%
Both negative yoy, with CSIQ at -265.89%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-32.48%
Negative yoy CFO while CSIQ is 0.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
6.25%
CapEx growth of 6.25% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
-100.00%
Negative yoy acquisition while CSIQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.24%
Growth of 29.24% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-104.70%
We reduce yoy invests while CSIQ stands at 0.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
151.93%
Debt repayment growth of 151.93% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
6.68%
Buyback growth of 6.68% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.